Literature DB >> 5541135

The influence of urinary pH on the plasma half-life of pseudoephedrine in man and dog and a sensitive assay for its determination in human plasma.

R G Kuntzman, I Tsai, L Brand, L C Mark.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5541135     DOI： 10.1002/cpt197112162

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  5 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

Review 2.  The pharmacological role of the kidney.

Authors:  D C Brater
Journal:  Drugs       Date:  1980-01       Impact factor: 9.546

3.  A comparison of plasma levels of L(+) pseudoephedrine following different formulations, and their relation to cardiovascular and subjective effects in man.

Authors:  C Bye; H M Hill; D T Hughes; A W Peck
Journal:  Eur J Clin Pharmacol       Date:  1975       Impact factor: 2.953

4.  Dose tolerance and pharmacokinetic studies of L (+) pseudoephedrine capsules in man.

Authors:  J Dickerson; D Perrier; M Mayersohn; R Bressler
Journal:  Eur J Clin Pharmacol       Date:  1978-12-01       Impact factor: 2.953

Review 5.  In search of an ideal drug for safer treatment of obesity: The false promise of pseudoephedrine.

Authors:  Antonio Munafò; Stefano Frara; Andrea Giustina; Renato Bernardini; Norberto Perico; Rosaria Di Mauro; Monica Cortinovis; Chiara Burgaletto; Giuseppina Cantarella; Giuseppe Remuzzi
Journal:  Rev Endocr Metab Disord       Date:  2021-05-04       Impact factor: 6.514
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.